Recurrent wheezing in three year-olds: Facts and opportunities;Sibilancias recurrentes en menores de tres años: Evidencias y oportunidades

Anales de Pediatria

Volumn 69, Issue 4, 2008, Pages 369-382

  Perez Yarza E G ^a   Sardon Prado O ^a   Korta Murua, J ^a  

^a HOSPITAL DONOSTIA   (Spain)

Author keywords

Antileukotrienes; Infant asthma; Inhaled glucocorticoids; Pre school children; Recurrent wheezing

Indexed keywords

BETA 2 ADRENERGIC RECEPTOR STIMULATING AGENT; FLUTICASONE; GLUCOCORTICOID; LEUKOTRIENE RECEPTOR BLOCKING AGENT; NITRIC OXIDE;

ALLERGIC ASTHMA; ASTHMA; BRONCHUS BIOPSY; CLINICAL FEATURE; EXPIRED AIR; HUMAN; LUNG FUNCTION; LUNG LAVAGE; MORBIDITY; PROVOCATION TEST; QUALITY OF LIFE; REVIEW; WHEEZING;

EID: 54849435458     PISSN: 16954033     EISSN: 16959531     Source Type: Journal    
DOI: 10.1157/13126564     Document Type: Article

References (161)

1. Warner JO, Naspitz CK. Third International Pediatric Consensus statement on the management of childhood asthma. International Pediatric Asthma Consensus Group. Pediatr Pulmonol. 1998;25:1-17.
2. Bacharier LB, Boner A, Carlsen KH, Eigenmann PA, Frischer T, Götz M, et al. Diagnosis and treatment of asthma in childhood: a PRACTALL consensus report. Allergy. 2008;63:5-34.
3. Saglani S, Lenney W. Difficult asthma in the pre-school child. Paediatr Respir Rev. 2004;5:199-206.
4. Kurukulaaratchy RJ, Fenn MH, Waterhouse LM, Matthews SM, Holgate ST, Arshad SH. Characterization of wheezing phenotypes in the first 10 years of life. Clin Exp Allergy. 2003;33:573-8.
5. Lau S, Illi S, Sommerfeld C, Niggemann B, Völkel K, Madloch C, et al. Transient early wheeze is not associated with impaired lung function in 7-yr-old children. Multicentre Allergy Study Group. Eur Respir J. 2003;21:834-41.
6. Martinez FD, Wright AL, Taussig LM, Holberg CJ, Halonen M, Morgan WJ. Asthma and wheezing in the first six years of life. The Group Health Medical Associates. N Engl J Med. 1995;332:133-8.
7. Stein RT, Holberg CJ, Morgan WJ, Wrght AL, Lombardi E, Taussig L, et al. Peak flow variability, methacholine responsiveness and atopy as markers for detecting different wheezing phenotypes in childhood. Thorax. 1997;52:946-52.
8. Taussig LM, Wright AL, Holberg CJ, Halonen M, Morgan WJ, Martinez FD. Tucson Children's Respiratory Study: 1980 to present. J Allergy Clin Immunol. 2003;111:661-75.
9. De Marco R, Locatelli F, Cerveri I, Bugiani M, Marinoni A, Giammanco G. Italian Study on Asthma in Young Adults study group. Incidence and remission of asthma: a retrospective study on the natural history of asthma in Italy. J Allergy Clin Immunol. 2002;110:228-35.
10. Martinez F. Clinical features of the wheezy infant. En: Martinez F, Godfrey S, editors. Wheezing disorders in the preschool child. New York: Martin Dunitz; 2003. p. 55-72.
11. Lowe LA, Simpson A, Woodcock A, Morris J, Murray CS, Custovic A, NAC Manchester Asthma and Allergy Study Group. Wheeze phenotypes and lung function in preschool children. Am J Respir Crit Care Med. 2005;171:231-7.
12. Morgan WJ, Stern DA, Sherrill DL, Guerra S, Holberg CJ, Guilbert TW, et al. Outcome of asthma and wheezing in the first six years of life: follow-up through adolescence. Am J Respir Crit Care Med. 2005;172:1253-8.
13. Ball TM, Castro-Rodríguez JA, Griffith KA, Holberg CJ, Martinez FD, Wright AL. Siblings, day-care attendance, and the risk of asthma and wheezing during childhood. N Engl J Med. 2000;343:538-43.
14. Hyvärinen MK, Kotaniemi-Syrjänen A, Reijonen TM, Korhonen K, Korppi MO. Teenage asthma after severe early childhood wheezing: An 11-year prospective follow-up. Pediatr Pulmonol. 2005;40:316-23.
15. Sigurs N, Gustafsson PM, Bjarnason R, Lundberg F, Schmidt S, Sigurbergsson F, et al. Severe respiratory syncitial virus bronchiolitis in infancy and asthma and allergy at age 13. Am J Respir Care Med. 2005;171:137-41.
16. García-García ML, Calvo C, Casas I, Bracamonte T, Rellán A, Gozalo F, et al. Human metapneumovirus bronchiolitis in infancy is an important risk factor for asthma at age 5. Pediatr Pulmonol. 2007;42:458-64.
17. Castro Rodríguez JA. ¿Cómo evaluar el riesgo de asma bronquial en lactantes y preescolares? Arch Bronconeumol. 2006;42:453-6.
18. Stein RT, Martínez FD. Asthma phenotypes in childhood: lessons from an epidemiological approach. Paediatr Respir Rev. 2004;5:155-61.
19. García-Marcos L, Castro-Rodríguez JA, Suárez-Varela MM, Garrido JB, Hernández GG, Gimeno AM, et al. A different pattern of risk factors for atopic and non-atopic wheezing in 9-12-year-old children. Pediatr Allergy Immunol. 2005;16:471-7.
20. Edwards CA, Osman LM, Godden DJ, Douglas JG. Wheezy bronchitis in childhood. A distinct clinical entitiy with lifelong significance? Chest. 2003;124:18-24.
21. Phelan PD, Robertson CF, Olinsky A. The Melbourne Asthma Study: 1964-1999. J Allergy Clin Immunol. 2002;109:189-94.
22. Spycher BD, Silverman M, Brooke AM, Minder CE, Kuehni CE. Distinguishing phenotypes of childhood wheeze and cough using latent class analysis. Eur Respir J. 2008;31:974-81.
23. Castro-Rodríguez JA, Holberg CL, Wrigth AL, Martínez FD. A Clinical Index to define risk of asthma in young children with recurrent wheezing. Am J Respir Crit Care Med. 2000;162:1403-6.
24. Guilbert TW, Morgan WJ, Zeiger RS, Bacharier LB, Boehmer SJ, Krawiec M, et al. Atopic characteristics of children with recurrent wheezing at high risk for the development of childhood asthma. J Allergy Clin Immunol. 2004;114:1282-7.
25. Goksor E, Amark M, Alm B, Gustafsson PM, Wennergren G. The impact pf pre- and post-natal smoke exposure on future asthma and bronchial hyper-responsiveness. Acta Pediatr. 2007;96:1030-5.
26. Piippo-Savolainen E, Korppi M. Wheezy babies-wheezy adults? Review on long-term outcome until adulthood after early childhood wheezing. Acta Pediatr. 2008;97:5-11.
27. Gemou-Engesaeth V, Bush A, Kay AB, Hamid Q, Corrigan CJ. Inhaled glucocorticoid therapy of childhood asthma is associated with reduced peripheral blood T cell activation and "Th2-type" cytokine mRNA expression. Pediatrics. 1997;99: 695-703.
28. Sly PD. Objective assessment of lung disease in wheezy infants: the time has come. Pediatric Pulmonol. 2006;41:798-800.
29. Douwes J, Gibson P, Pekkanen J, Pearce N. Non-eosinophilic asthma: importance and possible mechanisms. Thorax. 2002;57:643-8.
30. Payne D, Wilson NM, James A, Hablas H, Agrafioti C, Bush A. Evidence for different subgroups of difficult asthma in children. Thorax. 2001;56:345-50.
31. Bourgeois ML, Goncalves M, Le Clainche L, Benoist MR, Fournet JC, Scheinmann P, et al. Broncoalveolar cells in children < 3 years old with severe recurrent wheezing. Chest. 2002;122:791-7.
32. Jarjour NN, Gern JE, Kelly EA, Swenson CA, Dick CR, Busse WW. The effect of an experimental rhinovirus 16 infection on bronchial lavage neutrophils. J Allergy Clin Immunol. 2000;105:1169-77.
33. Marguet C, Jouen-Boedes F, Dean TP, Warner JO. Bronchoalveolar cell profiles in children with asthma, infantile wheeze, chronic cough or cystic fibrosis. Am J Respir Crit Care Med. 1999;159:1533-40.
34. Krawiec ME, Westcott JY, Chu HW, Balzar S, Trudeau JB, Schwartz LB, et al. Persistent wheezing in very young children is associated with lower respiratory inflammation. Am J Respir Crit Care Med. 2001;163:1338-43.
35. Bush A. How early do airway inflammation and remodeling occur? Allergol Int. 2008;57:11-9.
36. Wenzel SE. Asthma: defining of the persistent adult phenotypes. Lancet. 2006;368:804-13.
37. Saglani S, Payne DN, Zhu J, Wang Z, Nicholson AG, Bush A, et al. Early detection of airway wall remodeling and eosinophilic inflammation in preschool wheezers. Am J Respir Crit Care Med. 2007;176:858-64.
38. Barbato A, Turato G, Baraldo S, Bazzan E, Calíbrese F, Panizzolo C, et al. Epithelial damage and angiogenesis in the airways of children with asthma. Am J Respir Crit Care Med. 2006;174:975-81.
39. Payne DN, Rogers AV, Adelroth E, Bandi V, Guntupalli KK, Bush A, et al. Early thickening of the reticular basement membrane in children with difficult asthma. Am J Respir Crit Care Med. 2003;167:78-82.
40. Broide DH. Immunologic and inflammatory mechanisms that drive asthma progression to remodeling. J Allergy Clin Immunol. 2008;121:560-70.
41. Taylor DR, Pijnenburg MW, Smith AD, De Jongste JC. Exhaled nitric oxide measurements: clinical application and interpretation. Thorax. 2006;61:817-27.
42. Pijnenburg MW, De Jongste JC. Exhaled nitric oxide in childhood asthma: a review. Clin Exp Allergy. 2008;38:246-59.
43. Shaw DE, Berry MA, Thomas M, Green RH, Brightling CE, Wardlaw AJ, et al. The use of exhaled nitric oxide to guide asthma management. Am J Respir Crit Care Med. 2007;176:231-7.
44. Smith AD, Cowan JO, Brassett KP, Herbison GP, Taylor DR. Use of exhaled nitric oxide measurements to guide treatment in chronic asthma. N Engl J Med. 2005;352:2163-73.
45. Smith AD, Cowan JO, Brassett JP, Filsell S, McLachlan C, Monti-Sheehan G, et al. Exhaled nitric oxide: a predictor of steroid response. Am J Respir Crit Care Med. 2005;172:453-9.
46. Pijnenburg MW, Bakker EM, Hop WC, De Jongste JC. Titrating steroids on exhaled nitric oxide in children with asthma. Am J Respir Crit Care Med. 2005;172:831-6.
47. ATS/ERS Recommendations for Standardized Procedures for the Online and Offline Measurement of Exhaled Lower Respiratory Nitric Oxide and Nasal Nitric Oxide, 2005. Am J Respir Crit Care Med. 2005;171:912-30.
48. Buchvald F, Bisgaard H. FENO measured at fixed exhalation flow rate during controlled tidal breathing in children from the age of 2 yr. Am J Respir Crit Care Med. 2001;163:699-704.
49. Baraldi E, Scollo M, Zaramella C, Zanconato S, Zacchello F. A simple flow-driven method for online measurement of exhaled NO starting at the age of 4 to 5 years. Am J Respir Crit Care Med. 2000;162:1828-32.
50. Daniel PF, Klug B, Valerius NH. Exhaled nitric oxide in healthy young children during tidal breathing through a face-mask. Pediatr Allergy Immunol. 2007;18:42-6.
51. Silkoff PE, Bates CA, Meiser JB, Bratton DL. Single-breath exhaled nitric oxide in preschool children facilitated by a servo-controlled device maintaining constant flow. Pediatr Pulmonol. 2004;37:554-8.
52. Kharitonov SA, Barnes PJ. Exhaled Biomarkers. Chest. 2006;130:1541-6.
53. Ratnawati R, Morton J, Henry RL, Thomas PS. Exhaled breath condensate nitrite/nitrate and pH in relation to pediatric asthma control and exhaled nitric oxide. Pediatr Pulmonol. 2006;41:929-36.
54. Zacharasiewicz A, Wilson N, Lex C, Erin EM, Li AM, Hansel T, et al. Clinical use of noninvasive measurements of airway inflammation in steroid reduction in children. Am J Respir Crit Care Med. 2005;171:1077-82.
55. Formanek W, Inci D, Lauener RP, Wildhaber JH, Frey U, Hall GL. Elevated nitrite in breath condensates of children with respiratory disease. Eur Respir J. 2002;19:487-91.
56. ATS Workshop Proceedings. Exhaled nitric oxide and nitric oxide oxidative metabolism in exhaled breath condensate. Proc Am Thorac Soc. 2006;3:131-45.
57. Horvath I, Hunt J, Barnes PJ. ATS/ERS Task Force. Exhaled breath condensate: methodological recommendations and unresolved questions. Eur Respir J. 2005;26:523-48.
58. Moeller A, Franklin P, Hall GL, Horak F Jr, Wildhaber JH, Stick SM. Measuring exhaled breath condensates in infants. Pediatr Pulmonol. 2006;41:184-7.
59. Belda J. La inflamación en el asma: aspectos diagnósticos y marcadores de la evolución. Arch Bronconeumol. 2004;40:23-6.
60. Lex C, Jenkins G, Wilson NM, Zaacharasiewicz A, Erin Ed, Hansel TT, et al. Does sputum eosinophilia predict the response to systemic corticoesteroids in chlidren with difficult asthma? Pediatr Pulmonol. 2007;42:298-303.
61. Covar RA, Spahn JD, Martin RJ, Silkoff PE, Sundstrom DA, Murphy J, et al. Safety and application of induced sputum analysis in childhood asthma. J Allergy Clin Immunol. 2004;114:575-82.
62. Gibson PG, Simpson JL, Hankin R, Powell H, Henry RL. Relationship between induced sputum eosinophils and the clinical pattern of childhood asthma. Thorax. 2003;58:116-21.
63. Nagayama Y, Tsubaki T, Toba T, Nakayama S, Kiyofumi O. Analysis of sputum taken from wheezy and asthmatic infants and children, with special reference to respiratory infections. Pediatr Allergy Immunol. 2001;12:318-26.
64. Yamazaki T, Narita M, Sasaki N, Kenri T, Arakawa Y, Sasaki T. Comparison of PCR for sputum samples obtained by induced cough and serological test for diagnosis of Mycoplasma pneumoniae infection in children. Clin Vaccine Immunol. 2006;13:708-10.
65. Zar HJ, Tannenbaum E, Hanslo D, Hussey G. Sputum induction as a diagnostic tool for community acquired pneumonia in infants and young children form a high HIV prevalence area. Pediatric Pulmonol. 2003;36:58-62.
66. Lex C, Ferreira F, Zacharasiewicz, Nicholson AG, Haslam PL, Wilson NM, et al. Airway eosinophilia in children with severe asthma. Predictive values of noninvasive test. Am J Respir Crit Care Med. 2006;174:1286-91.
67. De Blic J, Midulla F, Barbato A, Clement A, Dab I, Eber E, et al. Bronchoalveolar lavage in children. ERS Task Force on bronchoalveolar lavage in children. European Respiratory Society. Eur Respir J. 2000;15:217-31.
68. Henderson AJW. Bronchoalveolar lavage. Arch Dis Child. 1994;70:167-9.
69. Nicolai T. Pediatric bronchoscopy. Pediatr Pulmonol. 2001;31:150-64.
70. Midulla F, De Blic J, Barbato A, Bush A, Eber E, Kotecha S, et al. ERS task force. Flexible endoscopy of paediatric airways. Eur Respir J. 2003;22:698-708.
71. Sly PD, Tepper R, Henschen M, Gappa M, Stocks J. Tidal forced expirations. ERS/ATS Task Force on Standards for Infant Respiratory Function Testing. European Respiratory Society/American Thoracic Society. Eur Respir J. 2000;16:741-8.
72. Frey U, Stocks J, Sly P, Bates J. Specification for signal processing and data handling used for infant pulmonary function testing. ERS/ATS Task Force on Standards for Infant Respiratory Function Testing. European Respiratory Society/American Thoracic Society. Eur Respir J. 2000;16:1016-22.
73. The Joint American Thoracic Society/European Respiratory Society Working Group on Infant Lung function. The raised volume rapid thoracoabdominal compression technique. Am J Respir Crit Care Med. 2000;161:1760-2.
74. Ranganathan SC, Hoo AF, Lum SY, Gotees I, Castle RA, Stocks J. Exploring the relationship between forced maximal flow at functional residual capacity and parameters of forced expiration from raised lung volume in healthy infants. Pediatr Pulmonol. 2002;33:419-28.
75. Jones MH, Howard J, Davis S, Kisling J, Tepper RS. Sensitivity of spirometric measurements to detect airway obstruction in infants. Am J Respir Crit Care Med. 2003;167:1283-6.
76. Ranganathan SC, Bush A, Dezateux C, Carr SB, Hoo AF, Lum S, et al. Relative ability of full and partial forced expiratory meneuvers to identify diminished airway function in infants with cystic fibrosis. Am J Respir Crit Care Med. 2000;161:763-8.
77. Modl M, Eber E, Weinhandl E, Gruber W, Zach MS. Assessment of bronchodilator responsiveness in infants with bronchiolitis. A comparison of the tidal and the raised volume rapid thoracoabdominal compression technique. Am J Respir Crit Care Med. 2000;161:763-8.
78. Mallol J, Andrade R, Auger F, Rodríguez J, Alvarado R, Figueroa L. Wheezing during the first year of life in infants from low-income population: A descriptive study. Allergol Immunopathol (Madr). 2005;33:257-63.
79. Robin B, Kim YJ, Huth J, Klocksieben J, Torres M, Tepper RS, et al. Pulmonary function in bronchopulmonary dysplasia. Pediatr Pulmonol. 2004;37:236-42.
80. Loland L, Bisgaard H. Feasibility of repetitive lung function measurements by raised volume rapid thoracoabdominal compression during methacholine challenge in young infants. Chest. 2008;133:115-22.
81. Rosenthal M, Cramer D, Bain SH, Denison D, Bush A, Warner JO. Lung function in white children aged 4 to 19 years: II-Single breath analysis and plethysmography. Thorax. 1993;48:803-8.
82. Stocks J, Godfrey S, Beardsmore C, Bar-Yishay E, Castile R. Plethysmographic measurements of lung volume and airway resistance. ERS/ATS Task Force on Standards for Infant Respiratory Function Testing. European Respiratory Society/American Thoracic Society. Eur Respir J. 2001;17:302-12.
83. Stocks J, Quanjer PH. Reference values for residual volume, functional residual capacity and total lung capacity. ATS Workshop on Lung Volume Measurements. Official Statement of The European Respiratory Society. Eur Respir J. 1995;8:492-506.
84. Bisgaard H, Nielsen KG. Plethysmographic measurements of specific airway resistance in young children. Chest. 2005;128:355-62.
85. Lowe L, Murray CS, Custovic A, Simpson BM, Kissen PM, Woodcock A, et al. Specific airway resistance in 3-year-old children: A prospective cohort study. Lancet. 2002;359:1904-8.
86. Nielsen KG, Bisgaard H. Discriminative capacity of bronchodilator response measured with three different lung function techniques in asthmatic and healthy children aged 2 to 5 years. Am J Respir Crit Care Med. 2001;164:554-9.
87. Dab I, Alexander F. A simplified approach to the measurement of specific airway resistance. Pediatr Res. 1976;10:998-9.
88. Lowe L, Murray CS, Custovic A, Simpson BM, Kissen PM, Woodcock A, et al. Specific airway resistance in 3-year-old children: A prospective cohort study. Lancet. 2002;359:1904-8.
89. Lowe L, Murray CS, Martin L, Deas J, Cashin E, Poletti G, et al. Reported versus confirmed wheeze and lung function in early life. Arch Dis Child. 2004;89:540-3.
90. O'Byrne PM, Inman MD. Airway hyperresponsiveness. Chest. 2003;123:411-6.
91. Beydon N, Davis SD, Lombardi E, Allen JL, Arets HG, Aurora P, et al. An official American Thoracic Society/European Respiratory Society statement: Pulmonary function testing in preschool children. Am J Respir Crit Care Med. 2007;175:1304-45.
92. Delacourt C, Benoist MR, Waernessyckle S, Rufin P, Brouard JJ, De Blic J, et al. Relationship between bronchial responsiveness and clinical evolution in infants who wheeze: a four-year prospective study. Am J Respir Crit Care Med. 2001;164:1382-6.
93. Klug B, Bisgaard H. Measurement of lung function in awake 2-4-year-old asthmatic children during methacholine challenge and acute asthma: a comparison of the impulse oscillation technique, the interrupter technique, and transcutaneous measurement of oxygen versus whole-body plethysmography. Pediatr Pulmonol. 1996;21:290-300.
94. Springer C, Godfrey S, Picard E, Uwyyed K, Rotschild M, Hananya S, et al. Efficacy and safety of methacholine bronchial challenge performed by auscultation in young asthmatic children. Am J Respir Crit Care Med. 2000;162:857-60.
95. De Frutos C, Pérez-Yarza EG, Aldasoro A, Emparanza JI, Callén M, Mintegui J. Agreement between tracheal auscultation and pulmonary function in methacholine bronchial inhalation challenge in asthmatic children. An Esp Pediatr. 2002;56:304-9.
96. De Mir Messa I, Moreno A, Cobos N, Liñán S, Gartner S, Vizmanos G. Estudio de la hiperrespuesta bronquial a la metacolina mediante la auscultación traqueal en niños sanos menores de 4 años. Arch Bronconeumol. 2007;43:156-60.
97. Godfrey S, Uwyyed K, Springer C, Avital A. Is clinical wheezing reliable as the endpoint for bronchial challenges in preschool children? Pediatr Pulmonol. 2004;37:193-200.
98. Saga R, Mochizuki H, Tokuyama K, Morikawa A. Relationship between bronchial hyperresponsiveness and development of asthma in wheezy infants. Chest. 2001;119:685-90.
99. Palmer LJ, Rye PJ, Gibson NA, Burton PR, Landau LI, Lesouëf PN. Airway responsiveness in early infancy predicts asthma, lung function, and respiratory symptoms by school age. Am J Respir Crit Care Med. 2001;163:37-42.
100. a parte). An Pediatr (Barc). 2006;65:51-66.
101. Global Iniatitive for Asthma (GINA). Global Strategy for Asthma Management and Prevention. Update 2007. www.ginasthma.org
102. British Guideline on the management of asthma (SIGN Updated Mayo 2008). A national clinical guideline. British Thoracic Society. Scottish Intercollegiate Guidelines Network. Update 2008. Disponible en: http://www.sign.ac.uk/ guidelines/fulltext/101/index.html
103. National Institutes of Health. National Asthma Education and Prevention Program. Expert Panel Report 3 (NAEPP EPR-3). Guidelines for the Diagnosis and Management of Asthma 2007. Disponible en: http://www.nhlbi.nih.gov/guidelines/ asthma/index.htm
104. Kuehni CE, Swiss Paediatric Pulmonology Group. Phenotype specific treatment of obstructive airways disease in infancy and childhood: new recommendations of the Swiss Paediatric Pulmonology Group. Swiss Med Wkly. 2005;135:95-100.
105. Castillo JA, De Benito J, Escribano A, Fernández M, García de la Rubia S, Garde J, et al. Grupo de trabajo de para el Consenso sobre Tratamiento del Asma Infantil. Consenso sobre tratamiento del asma en pediatría. An Pediatr (Barc). 2007;67:253-73.
106. Guilbert TW, Morgan WJ, Zeiger RS, Mauger DT, Boehmer SJ, Szfler SJ, et al. Long-term inhaled corticosteroids in preschool children at high risk for asthma. N Engl J Med. 2006;354:1985-97.
107. Bisgaard H, Sci DM, Hermansen MN, Loland L, Halkjaer LB, Buchvald F. Intermittent inhaled corticosteroids in infants with episodic wheezing. N Engl J Med. 2006;354:1998-2005.
108. Murray CS, Woodcock A, Langley SJ, Morris J, Custovic A, for the IFWIN study team. Secondary prevention of asthma by the use of Inhaled Fluticasone propionate in Wheezy INfants (IFWIN): Double-blind, randomised, controlled study. Lancet. 2006;368:754-62.
109. Bisgaard H, Allen D, Milanowski J, Kalev I, Willis L, Davies P. Twelve-month safety and efficacy of inhaled fluticasone propionate in children aged 1 to 3 years with recurrent wheezing. Pediatrics. 2004;113:e87-e94.
110. Carlsen KC, Stick S, Kamin W, Cirule I, Hughes S, Wixon C. The efficacy and safety of fluticasone propionate in very young children with persistent asthma symptoms. Respir Med. 2005;99:1393-402.
111. Wasserman RL, Baker JW, Kim KT, Blake KV, Scott CA, Wu W, et al. Efficacy and safety of inhaled fluticasone propionate chlorofluorocarbon in 2- to 4-year-old patients with asthma: results of a double-blind, placebo-controlled study. Ann Allergy Asthma Immunol. 2006;96:808-18.
112. Qaqundah PY, Sugerman RW, Ceruti E, Maspero JF, Kleha JF, Scott CA, et al. Efficacy and safety of fluticasone propionate hydrofluoroalkane inhalation aerosol in preschoolage children with asthma: A randomized, double-blind, placebo-controlled study. J Pediatr. 2006;149:663-70.
113. Teper AM, Kofman CD, Szulman GA, Vidaurreta SM, Maffey AF. Fluticasone improves pulmonary function in children under 2 years old with risk factors for asthma. Am J Respir Crit Care Med. 2005;171:587-90.
114. Hofhuis W, Van der Wiel EC, Nieuwhof EM, Hop WC, Affourtit MJ, Smit FJ, et al. Efficacy of fluticasone propionate on lung function and symptoms in wheezy infants. Am J Respir Crit Care Med. 2005;171:328-33.
115. Moeller A, Franklin P, Hall GL, Turner S, Straub D, Wildhaber JH, et al. Inhaled fluticasone dipropionate decreases levels of nitric oxide in recurrenty wheezy infants. Pediatr Pulmonol. 2004;38:250-5.
116. McKean M, Ducharme F. Inhaled steroids for episodic viral wheeze of childhood (Cochrane Review). The Cochrane Library, Issue 4, 2002.
117. Reijonen T, Korppi M, Kuikka L, Remes K. Anti-inflammatory therapy reduces wheezing after bronchiolitis. Arch Pediatr Adolesc Med. 1996;150:512-7.
118. Kajosaari M, Syvanen P, Forars M, Juntunen-Backman K. Inhaled corticosteroids during and after respiratory syncytial virus-bronchiolitis may decrease subsequent asthma. Pediatr Allergy Immunol. 2000;11:198-202.
119. Schokker S, Kooi EM, De Wries TW, Brand PL, Mulder PG, Duiverman EJ, et al. Inhaled corticosteroids for recurrent respiratory symptoms in preschool children in general practice: randomized controlled trial. Pulm Pharmacol Ther. 2008;21:88-97.
120. Roorda RJ, Mezei G, Bisgaard H, Maden C. Response of preschool children with asthma symptoms to fluticasone propionate. J Allergy Clin Immunol. 2001;108:540-6.
121. Saglani S, Wilson N, Bush A. Should preschool wheezers ever be treated with inhaled corticosteroids? Semin Respir Crit Care Med. 2007;28:272-85.
122. Knorr B, Franchi LM, Bisgaard H, Vermeulen JH, LeSouef P, Santanello N, et al. Montelukast, a leukotriene receptor antagonist, for the treatment of persistent asthma in children aged 2 to 5 years. Pediatrics. 2001;108:e48.
123. Bisgaard H, Zielen S, García-García ML, Johnston SL, Gilles L, Menten J, et al. Montelukast reduces asthma exacerbations in 2-5 year old children with intermittent asthma. Am J Respir Crit Care Med. 2005;171:315-22.
124. Robertson CF, Price D, Henry R, Mellis C, Glasgow N, Fitzgerald D, et al. Short course montelukast for intermittent asthma in children: A randomized controlled trial. Am J Respir Crit Care Med. 2007;175:323-9.
125. Johnston NW, Mandhane PJ, Dai J, Duncan JM, Greene JM, Lambert K, et al. Attenuation of the September epidemic of asthma exacerbations in children: A randomized, controlled trial of montelukast added to usual therapy. Pediatrics. 2007;120:e702-e12.
126. Hakim F, Vilozni D, Adler A, Livnat G, Tal A, Bentur L. The effect of montelukast on bronchial hyperreactivity in preschool children. Chest. 2007;131:180-6.
127. Straub DA, Moeller A, Minocchieri S, Hamacher J, Sennhauser FH, Hall GL, et al. The effect of montelukast on lung function and exhaled nitric oxide in infants with early childhood asthma. Eur Respir J. 2005;25:289-94.
128. Straub DA, Minocchieri S, Moeller A, Hamacher J, Wildhaber JH. The effect of montelukast on exhaled nitric oxide and lung function in asthmatic children 2 to 5 years old. Chest. 2005;127:509-14.
129. Richeldi L, Ferrara G, Fabbri LM, Lasserson TJ, Gibson PG. Macrolides for chronic asthma. Cochrane Database Syst Rev. 2005;20(3):CD002997.
130. Shinkai M, Rubin BK. Macrolides and airway inflammation in children. Paediatr Respir Rev. 2005;6:227-35.
131. Sharma S, Jaffe A, Dixon G. Immmunomodulatory effects of macrolide antibiotics in respiratory diseases. Therapeutic implications in asthma and cystic fibrosis. Pediatr Drugs. 2007;9:107-18.
132. Mónica Fonseca A, Okada PJ, Bowlare KL, Chávez Bueno S, Mejías A, Ríos AM, et al. Effect of clarithromycin on cytokines and chemokines in children with an acute exacerbation of recurrent wheezing: A double-blind, randomized, placebo-controlled trial. Ann Allergy Asthma Immunol. 2006;97:457-63.
133. Prendiville A, Green S, Silverman M. Airway responsiveness in wheezy infants: evidence for functional beta adrenergic receptors. Thorax. 1987;42:100-4.
134. Reinhardt D, Zehmisch T, Becker B, Nagel-Hiemke M. Age-dependency of alpha- and beta-adrenoceptors on thrombocytes and lymphocytes of asthmatic and nonasthmatic children. Eur J Pediatr. 1984;142:111-6.
135. Bentur L, Kerem E, Canny G, Reisman J, Schuh S, Stein R, et al. Response of acute asthma to a beta 2 agonist in children less than two years of age. Ann Allergy. 1990;65:122-6.
136. Chavasse R, Seddon P, Bara A, McKean M. Short acting beta agonists for recurrent wheeze in children under 2 years of age. Cochrane Database Syst Rev. 2002;(3):CD002873.
137. Lodrup Carlsen KC, Pettersen M, Carlsen KH. Is bronchodilator response in 2-year-old children associated with asthma risk factors? Pediatr Allergy Immunol. 2004;15:323-30.
138. Le Souef PN. Aerosol delivery to wheezy infants: a comparison between a nebulizer and two small volume spacer. Pediatr Pulmonol. 1997;23:212-6.
139. Rubilar L, Castro-Rodríguez JA, Girardi G. Randomized trial of salbutamol via metered-dose inhaler with spacer versus nebulizer for acute wheezing in children less than 2 years of age. Pediatr Pulmonol. 2000;29:264-9.
140. Delgado A, Chou KJ, Silver EJ, Crain EF. Nebulizers versus metered-dose inhalers withs spacers for broncodilator therapy to treat wheezing in children aged 2 to 24 months in a pediatric emergency department. Arch Pediatr Adolesc Med. 2003;157:76-80.
141. Cates CJ, Rowe BH, Bara A. Holding chambers versus nebulizers for beta-agonist treatment of acute asthma (Cochrane Review). En: The Cochrane Library, Issue 4. Chichester, UK: John Wiley & Sons Ltd; 2003.
142. Kraemer R, Frey U, Sommer CW, Russi E. Short-term effect of albuterol, delivered via a new auxiliary device, in wheezy infants. Am Rev Respir Dis. 1991;144:347-51.
143. Alario AJ, Lewander WJ, Dennehy P, Seifer R, Mansell AL. The efficacy of nebulized metaproterenol in wheezing infants and young children. Am J Dis Child. 1992;146:412-8.
144. Bentur L, Canny GJ, Shields MD, Kerem E, Schuh S, Reisman JJ, et al. Controlled trial of nebulized albuterol in children younger than 2 years of age with acute asthma. Pediatrics. 1992;89:133-7.
145. Sly PD, Lanteri CJ, Raven JM. Do wheezy infants recovering from bronchiolitis respond to inhaled salbutamol? Pediatr Pulmonol. 1991;10:36-9.
146. Clarke JR, Aston H, Silverman M. Delivery of salbutamol by metered dose inhaler and valved spacer to wheezy infants: effect on bronchial responsiveness. Arch Dis Child. 1993;69:125-9.
147. Hayden MJ, Wildhaber JH, LeSouef PN. Bronchodilator responsiveness testing using raised volume forced expiration in recurrently wheezing infants. Pediatr Pulmonol. 1998;26:35-41.
148. Chavasse RJ, Bastian-Lee Y, Richter H, Hilliard T, Seddon Pl. Inhaled salbutamol for wheezy infants: a randomised controlled trial. Arch Dis Child. 2000;82:370-5.
149. O'Callaghan C, Milner AD, Swarbrick A. Paradoxical deterioration in lung function after nebulised salbutamol in wheezy infants. Lancet. 1986;2:1424-5.
150. Prendiville A, Green S, Silverman M. Paradoxical response to nebulised salbutamol in wheezy infants, assessed by partial expiratory flow-volume curves. Thorax. 1987;42:86-91.
151. Hofhuis W, Van der Wiel EC, Tiddens HA, Brinkhorst G, Holland WP, De Jongste JC, et al. Bronchodilation in infants with malacia or recurrent wheeze. Arch Dis Child. 2003;88:246-9.
152. Chavasse R, Seddon P, Bara A, McKean M. Short acting beta agonists for recurrent wheeze in children under 2 years of age. Cochrane Database Syst Rev. 2002;(3):CD002873.
153. Schuh S, Johnson DW, Callahan S, Canny G, Levison H. Efficacy of frequent nebulized ipratropium bromide added to frequent high-dose albuterol therapy in severe childhood asthma. J Pediatr. 1995;126:639-45.
154. Plotnick LH, Ducharme FM. Should inhaled anticholinergics be added to beta2 agonists for treating acute childhood and adolescent asthma? A systematic review. BMJ. 1998;317:971-7.
155. Everard ML, Bara A, Kurian M, Elliott TM, Ducharme F, Mayowe V. Anticholinergic drugs for wheeze in children under the age of two years. Cochrane Database Syst Rev. 2005;(3):CD001279.
156. Rowe BH, Spooner C, Ducharme FM, Bretzlaff JA, Bota CW. Early emergency department treatment of acute asthma with systemic corticosteroids (Cochrane Review). En: The Cochrane Library, Issue 3. Chichester, UK: John Wiley & Sons Ltd; 2001.
157. Fox G, Marsh MJ, Milner AD. Treatment of recurrent acute wheezing episodes in infancy with oral salbutamol and prednisolone. Eur J Pediatr. 1996;155:512-6.
158. Rowe BH, Spooner C, Ducharme FM, Bretzlaff JA, Bota CW. Corticosteroids for preventing relapse following acute exacerbations of asthma (Cochrane Review). En: The Cochrane Library, Issue 3. Chichester, UK: John Wiley & Sons Ltd; 2001.
159. Tal A, Levy N, Bearman JE. Methylprednisolone therapy for acute asthma in infants and toddlers: a controlled clinical trial. Pediatrics. 1990;86:350-6.
160. Ommen A, Lambert PC, Griqq J. Efficacy of short course of parent-iniated oral prednisolone for viral wheeze in children aged 1-5 years: randomised controlled trial. Lancet 2003;362:1433-8.
161. Vuillermin P, South M, Robertson C. Parent-initiated oral corticosteroid therapy for intermittent wheezing illnesses in children (Cochrane Review). En: The Cochrane Library, Issue 3. Chichester, UK: John Wiley & Sons Ltd; 2006.